Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Top Cited Papers
Open Access
- 15 May 2008
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (20) , 2107-2116
- https://doi.org/10.1056/nejmoa0707064
Abstract
The incremental usefulness of adding multiple biomarkers from different disease pathways for predicting the risk of death from cardiovascular causes has not, to our knowledge, been evaluated among the elderly.Keywords
This publication has 29 references indexed in Scilit:
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general populationEuropean Heart Journal, 2007
- Use and Misuse of the Receiver Operating Characteristic Curve in Risk PredictionCirculation, 2007
- Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and DeathNew England Journal of Medicine, 2006
- The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for WomenAnnals of Internal Medicine, 2006
- Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old MenCirculation, 2006
- Cystatin C and the Risk of Death and Cardiovascular Events among Elderly PersonsNew England Journal of Medicine, 2005
- Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening MarkerAmerican Journal of Epidemiology, 2004
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000